Home When to Seek Care Raskin's Arc Four Pillars The Antibiotic Belief Cycle
ShortenYourColds.com · Russell W. Raskin, MD

Yes, You Do Have Sinusitis

The word only sounds like a diagnosis. Here is what it actually means — and when it becomes the rare thing that changes everything.
Listen to this article
Audio coming soon

You came in because of the pressure behind your eyes, the congestion that won't quit, and the mucus that's turned a color you don't like. Maybe someone already told you it's "just a cold," and it didn't sit right, because this doesn't feel like just a cold. So let's get one thing out of the way first: you're right. You do have sinusitis.

Here's what tends to get lost, though. You've had sinusitis every time you've ever had a cold. The word only sounds like a diagnosis. Break it apart and it means inflammation of the sinuses — sinus plus -itis, the same way arthritis means inflamed joints. Every head cold is a virus setting up shop in your nose and sinuses, and inflammation is your immune system showing up to fight. So the swelling, the pressure, the congestion — that is sinusitis. It was sinusitis on day one. It has a name that sounds serious, and somewhere along the way that name got welded to a prescription. That's the part we need to take apart.

Think about how a pimple forms. A pore gets blocked, the skin around it gets inflamed, and most of the time your body works it open on its own. Most pimples don't need an oral antibiotic. Your sinuses work the same way.

The bacteria that could eventually cause true secondary bacterial sinusitis aren't coming from outside. They're already living in your nose right now — harmless, normal residents. For them to become a problem, conditions have to change. The sinus has to stay blocked. The environment has to become stagnant. Your own bacteria have to overgrow behind that blockage — a process that tends to occur slowly. That process doesn't happen in a day or two. It doesn't happen in the first week. It requires time — and that time puts it well outside the window of your average head cold.

Which is why you cannot get ahead of it with antibiotics. There is nothing to kill on day three, because on day three there is no bacterial infection to kill. There's a virus, a blocked sinus, and your immune system doing its job. An antibiotic taken early doesn't prevent the rare bacterial version from developing. It just exposes you and your native bacteria to a drug you don't need — and in most cases, never will.

What you can do is optimize the conditions your immune system works in — and do everything safely possible to help your body keep those sinuses open and draining. That's what this platform is built around. Not a shortcut. Not a substitute for your immune system. A set of tools designed to help it do its job better.

There are things you can do right now that matter. Staying well hydrated keeps your mucus thin and your drainage pathways moving — and dehydrated, thickened mucus is one of the conditions that sets the stage for secondary bacterial complications. Nasal saline irrigation has real evidence behind it: it improves mucus clearance, supports ciliary function, and disrupts the stagnant environment bacteria need to overgrow. Nasal steroid sprays reduce the swelling that's blocking your drainage channels. These are not substitutes for your immune system. They are ways to give it better conditions to work in — and to keep those sinuses from becoming the closed, stagnant cavity that true secondary bacterial sinusitis requires.

Here's something worth sitting with. If you've been treated for sinusitis with an antibiotic before — and felt better — that doesn't necessarily mean you had a bacterial sinus infection. It may mean you had a viral sinus infection that resolved on its own, on the same timeline it was always going to resolve, while you happened to be taking an antibiotic. The antibiotic gets the credit. Your immune system did the work. This isn't a criticism of anyone who treated you. It's how the illness behaves — and it's exactly why the research on antibiotic prescribing for sinusitis looks the way it does.

And if you've had sinusitis — that congestion and pressure — every year of your adult life, and been treated with an antibiotic each time, that's not one unnecessary exposure. That's a lifetime of them. Each one carrying real side effects, and some carrying consequences that are difficult to measure.

Now Let's Go Back to That Color

You noticed it. Maybe it's what brought you in. Yellow, green, thick — the kind that feels like evidence of something bacterial that needs to be addressed.

It isn't. It never was.

The color in your mucus comes from inflammatory cells — white blood cells that have done their job and died. It is the aftermath of your immune system working, not a signal that bacteria have taken over. The color tells you your immune system is engaged. That's it.

R.W. Raskinism

Green doesn't mean go — get an antibiotic.

Green means your immune system is doing exactly what it is supposed to do. Let it.

But how will you know when your sinus cold has crossed into territory that actually warrants an antibiotic, a return visit, or a closer look?

Here is something worth saying clearly: when your doctor told you that you had a sinus infection, they were right. When you develop congestion, pressure, and facial symptoms in the setting of a cold, your sinuses are inflamed and infected — that is a sinus infection, and the term is accurate. What has been incorrect, for decades, is what happened next. Because almost universally, a sinus infection that begins with a cold is a viral sinus infection. The virus is the infection. And the treatment that followed — the antibiotic — was never aimed at what was actually causing your illness. It was aimed at bacteria that, in most cases, were never meaningfully involved. By treating viral sinus infections with antibiotics, we accidentally taught an entire generation of patients that congestion means bacteria, and bacteria means a prescription. That is the belief we are here to correct. Not the diagnosis. The conclusion.

What a Sinus Cold Actually Does

A viral sinus infection — a sinus cold — follows a pattern. It starts the way most colds start: a scratchy throat, some congestion, a general sense that something is coming. Over the next two to four days it builds. The congestion deepens. The pressure behind your eyes and across your cheeks increases. Your mucus thickens and changes color. Your head aches. You feel genuinely unwell — not just tired, but that specific sick feeling where you know your body is in the middle of something. This is the peak. It is uncomfortable and it is supposed to be. Your immune system is working hard — and working correctly. The misery is the medicine.

Then, slowly, things begin to shift. The pressure starts to ease. The congestion loosens. The color begins to clear. Your energy starts to return. That full arc — from first symptom to feeling like yourself again — typically runs one to two weeks. Sometimes a few days longer. That is normal. That is a viral sinus infection doing exactly what it is supposed to do.

The Signals That Should Override Waiting

There are signals that should override your instinct to wait. These are not all-inclusive — there are other reasons to be seen that your doctor will recognize — but two of them are worth knowing by name.

The first is a clock. Most viral sinus infections show some sign of improvement within one to two weeks. If you are in that window and nothing has shifted — not better, not worse, just stuck — that is worth attention. No movement after one to two weeks is a reason to be seen. But if you are getting worse — not fluctuating, not having a bad day, but on a clear downward trajectory — that does not wait for a clock. That is a reason to be seen regardless of where you are in the timeline.

Overriding Signal One
No improvement — or getting worse. The trend that doesn't wait for a number of days.
WORSE BETTER DAY 1 DAY 3 DAY 5 DAY 7 DAY 10 DAY 14 STUCK — NO IMPROVEMENT OR GETTING WORSE EXPECTED RECOVERY

The second is a bit harder to describe, but easier to recognize when it happens to you. You were getting better. Not just a good afternoon — a real improvement over a day or two. And then you got worse again. Not a normal fluctuation. Not one bad morning after a good night. A genuine reversal of a trajectory that was clearly heading in the right direction. That is what we call double worsening. Normal ups and downs during a sinus cold are not double worsening. Feeling slightly better one afternoon and worse the next morning is not double worsening. A clear improvement that reverses — that is.

Neither of these signals definitively means you have true secondary bacterial sinusitis. They mean the picture has changed enough that it deserves a fresh look.

Overriding Signal Two
Double worsening — a clear improvement that reverses. This is the signal with a name.
WORSE BETTER DAY 1 DAY 3 DAY 5 DAY 7 DAY 10 DAY 14 IMPROVEMENT DOUBLE WORSENING Clear improvement that reverses — not a bad day, a changed trajectory

When It Becomes the Rare Thing

When true secondary bacterial sinusitis does develop — when the blockage has persisted long enough, conditions have ripened, and your own bacteria have overgrown behind that blocked sinus — pus begins to collect in that closed cavity. And when pus builds in a space that has nowhere to drain, it tends to announce itself. Not as a worse version of what you had. As something different in kind.

The pressure changes character. The pain becomes more focal, more intense. A fever that had resolved may return, or one may arrive for the first time. You feel systemically unwell in a way that is hard to articulate but unmistakable when it happens — not just sick, but a different category of sick. The way you would never confuse a chest cold with pneumonia, even without a medical degree. You just know pneumonia is a different animal.

That is how I describe true secondary bacterial sinusitis to my patients.

R.W. Raskinism

Pneumonia of your face.

Not because it involves your lungs. Because it is that level of illness. And when you feel it — when the sinus cold you were managing becomes that — that is the moment antibiotics have a legitimate role. Not on day three because the mucus turned yellow. Not because you've had sinusitis before and antibiotics worked. Because the illness itself changed category. That is the signal. That is the threshold. And it is one you will recognize when you reach it.

What Changes Now

If you have spent years reaching for an antibiotic every time that congestion and pressure built — or being handed one — you were not wrong to trust what you were told. The medical culture that built that reflex wasn't operating without reason. The science has evolved, the evidence has caught up, and now we know better. All of us — patients and physicians alike.

Most of what you have called sinus infections in your lifetime were likely viral — particularly in recent decades, as the pathogen landscape has genuinely shifted. The antibiotic that accompanied them was powerless against the infection that was actually there — and doing nothing good.

What changes now is not that you stop seeking care. It is that you know what you are looking for. You understand the arc. You know the difference between a sinus cold doing its job and a signal that something has actually changed. You know what double worsening means. You know what warrants a visit and what warrants patience. That is not a small thing. That is the difference between a patient who reacts and a patient who understands.

R.W. Raskinism

We know better now. And so do you.

For informational and educational purposes only. Does not constitute medical advice. If you are concerned about your symptoms, or if you experience severe or rapidly worsening illness, seek care from a qualified clinician.

HCP Guide — Peer to Peer · Russell W. Raskin, MD

Sinusitis: The Line Just Moved Again

Watchful waiting is now Level A initial management for uncomplicated ABRS — regardless of severity. The defensible position is no longer the prescription.
Listen to this article
Audio coming soon

For years, watchful waiting carried a qualifier: it was the strategy for mild illness. Severe enough, and even the evidence-based move was to prescribe. That qualifier is gone.

The 2025 AAO-HNS Adult Sinusitis Update now recommends watchful waiting as an initial management option for all adults with uncomplicated ABRS — regardless of severity. Note the B. Acute bacterial rhinosinusitis. Yes, bacterial.

The guidance isn't telling you to withhold antibiotics only when you suspect a virus. It's telling you that even when the clinical picture points toward bacteria, immediate antibiotics are not the required first move.

Sit with that for a moment.

Watchful waiting is now appropriate initial management for the exact category we were all trained to treat.

This is not a soft recommendation. The guideline graded it Level A — built on multiple systematic reviews of randomized trials. Stop and consider how rarely we see that. A Level A, evidence-based recommendation to withhold a treatment is uncommon in any field of medicine. Most of what guides our prescribing rests on observational data or consensus. This rests on the strongest tier of evidence we have. The guideline stated its quality-improvement goal plainly: make it explicit to clinicians and patients that not prescribing antibiotics for clinically diagnosed ABRS is an appropriate initial strategy.

There is a practical implication here that deserves to be said out loud. A great deal of antibiotic overprescribing is not driven by clinical reasoning at all. It is defensive. The clinician reaches for the pad because not prescribing feels like the riskier position — the one that gets second-guessed if the patient worsens, the one that feels exposed. A Level A recommendation to withhold changes that equation. When the strongest tier of evidence, codified in a major specialty guideline, tells you that watchful waiting is appropriate initial management, the defensible position is no longer the prescription. It is the restraint. You are not going out on a limb by not treating. You are standing exactly where the guideline tells you to stand.

For me, this confirms something I've believed for a long time. The management of sinusitis has been laden with overtreatment — reflexive antibiotics aimed at a problem antibiotics were never the right tool for. The treatment was always time, and help reducing the congestion and inflammation that obstruct drainage. Open the sinus, or help the body open it. That is the intervention. Most patients presenting with sinus symptoms are early in the course of what is almost always a viral upper respiratory infection. You already knew that. What you may not have had was explicit, top-tier guideline cover to act on it. Now you do. Even when the presentation reads as early bacterial, or frankly bacterial, watchful waiting is the sanctioned approach. The goal in that moment is not sterilization. It is drainage. Open the sinus, support the host, and let the small subset that genuinely needs an antibiotic declare itself.

The Evidence That Earned It

The recommendation didn't appear from nowhere. It rests on a body of randomized data that has been remarkably consistent for years.

Start with natural history. In the Cochrane review — 15 trials, over 3,000 adults — 46% of patients recovered within one week without any antibiotic, and 64% within two weeks. The illness resolves on its own in the substantial majority of patients, on a timeline antibiotics barely touch. [1]

Then the effect size. For every 18 to 19 patients treated, antibiotic therapy led to one additional patient recovering faster than those given placebo. That is the number needed to treat. Against it sits a number needed to harm of 8 — meaning a patient is more than twice as likely to be harmed by the antibiotic as helped by it. Nausea, diarrhea, rash, candidiasis at the low end; C. difficile, anaphylaxis, and Stevens-Johnson at the rare and serious end. The NNH of 8 is not a footnote. It is the center of the argument. [1][2]

And the complication question — the one that drives the defensive prescribing we just discussed. The fear is that not treating lets a sinus infection progress to something orbital or intracranial. The data do not support that fear. Serious suppurative complications were vanishingly rare in the Cochrane review — a single case, a brain abscess, among more than 3,000 patients, and it occurred in a patient who had not received antibiotics. There is no evidence in this data that routine antibiotics prevent the catastrophic complication. Treating every patient to prevent that rare event means harming a great many to prevent something antibiotics have not been shown to reliably prevent. [1][2]

That is the evidence base. High rates of spontaneous recovery, a marginal and slow benefit, a harm profile that exceeds the benefit, and no demonstrated protection against the serious complications we prescribe out of fear of.

The Exam Room

The problem of antibiotic overuse in sinusitis is not a knowledge gap. You know the evidence. It is a behavioral and communication problem — and the interventions that work are about how you run the encounter, not what you know. Here are the moves with evidence behind them. [3][4]

1Relabel at diagnosis.

"Sinus cold," not "sinus infection." The word drives the expectation. Change the word, change what the patient believes they need.

2Foreshadow the virus early.

Name it before you finish the exam. The word viral is the most useful word in the room — use it early and use it often. "Everything I'm seeing so far points to a virus — a viral sinus infection — and these will likely run their course on their own. And as you're aware, antibiotics don't treat viruses." Then plant the mechanism that makes watchful waiting make sense: you don't catch a bacterial sinus infection, you develop one — slowly, over time, behind a sinus that stays blocked. And most people never develop one at all. If we can keep that sinus draining and keep your own bacteria from getting stuck behind a blockage over the next couple of weeks, you are unlikely to ever get there. There is nothing bacterial to treat today, and the goal is to keep it that way. Said up front, this sets the expectation before the patient has formed the request. Resistance is built on surprise. Name the virus, remind them antibiotics don't treat it, and explain that the bacterial version takes time to develop — and there's no surprise left to resist.

3Send them with a plan, not a script.

The empty-handed feeling is what drives the request for an antibiotic — but in practice you're no longer handing anyone a paper plan. The plan is your discharge instructions, your after-visit summary, the resource you point them to. Populate it with something real: saline irrigation, nasal steroid, analgesia, hydration, and the specific milestones for when to return. Point them to the platform as the place that explains the why behind all of it. A patient who leaves with a clear plan and an explanation does not feel untreated. They feel managed.

4Delay with a fill-date, not a handshake.

A safety-net prescription only works if the delay is structural. Use your EMR's earliest-fill-date function — on most systems, a calendar field — to set a fill date several days out. Without it, the patient fills it in the pharmacy parking lot and the strategy is dead on arrival. The fill-date tells the pharmacist what your verbal instructions cannot enforce: this is not to be started today. Hand a patient an ordinary prescription and 93% fill it. Put a fill-date on it and that drops to about 27%. The mechanism is the whole game. [4]

The Patient Who Actually Warrants Treatment

If you're practicing good evidence-based medicine, you're starting from the understanding that most patients don't have a bacterial infection and don't warrant an antibiotic. So it's worth being clear about what you're actually treating in the less common case when they do — because it isn't symptom duration, and it never was about speed of recovery.

Be honest about symptom duration first, because it cuts both ways. Most patients recover within two weeks — but a real minority run longer, into the three-to-four-week range, and those are the patients sitting in front of you wanting an answer. Antibiotics may have an effect on how long symptoms last. It is just a small one — one additional patient better faster for every 18 or 19 treated, against a number needed to harm of 8. So duration is not nothing. It is simply not the main reason to treat the genuine case. When you do treat, here is what the antibiotic is actually doing.

A longer course does raise the likelihood that normal sinonasal flora have overgrown behind an obstructed cavity. It shifts the prior. But on its own it clinches nothing — plenty of viral courses run long.

Double worsening carries more weight — likely more sensitive than duration alone for a secondary bacterial process. But it, too, is a signal, not a confirmation.

What clinches it is convergence. The patient with sufficient duration, the proper clinical picture, and the development of systemic symptoms — especially fever, and in select cases radiographic evidence — is a categorically more specific presentation than any one of those findings alone. That is the patient with a true secondary bacterial sinusitis. That is the patient in whom antibiotics, among other measures, carry the most benefit.

R.W. Raskinism

Treat the convergence, not the calendar, and not the color.

When you do treat that patient, it's worth being clear about what the antibiotic is actually doing — because it's a smaller story than the prescription implies. The overgrown flora behind the obstruction are themselves an inflammatory stimulus, driving the edema that keeps the sinus blocked. Reducing the bacterial burden can interrupt that loop, letting the sinus open and drain a little sooner than it otherwise would. That is the mechanism. Its endpoint is a modest shortening of duration in an illness that, even here, was largely going to resolve on its own.

I'll add one piece of my own clinical reasoning, labeled as reasoning rather than trial data: in the genuinely progressing case, I believe there is value in reducing the chance that infection in a closed space extends into structures that tolerate it poorly. The trials don't demonstrate that antibiotics reliably prevent those rare complications, so I won't claim they do. But it informs my judgment in the small number of patients whose course has clearly declared itself.

That is the honest case. A convergence of findings that identifies the right patient, a modest effect on duration through a plausible mechanism, and a containment rationale I hold but cannot prove. It is not an argument for reaching for the pad. It is an account of what the drug is doing in the few who genuinely warrant it — and why, for everyone else, there is nothing for it to do.

The Close

A patient who has read the companion to this article arrives in your exam room already different. They have been told — before they ever sat on your table — that the color of their mucus has no clinical significance, that their sinus cold is viral, that antibiotics don't treat viruses, and that a true bacterial sinus infection is something that develops slowly rather than something they caught this week. The foreshadowing you would normally have to do in the visit has, in part, already been done.

That is what this platform is built to do for you. Not to replace the encounter — to prepare the patient for it. The reframing, the arc, the meaning of double worsening, the milestones for when to return: a patient who absorbs that before they walk in is a patient who is easier to manage, more satisfied with a non-antibiotic plan, and less likely to leave feeling untreated.

None of this is anti-physician. It never has been. The reflex to prescribe was built over decades by a culture, a fear of liability, and a pathogen landscape that has genuinely changed. We know better now. The guideline knows better now. This is simply an effort to close the distance between what the evidence has said for years and what still happens in the room — and to hand you, and your patient, the language to close it together.

Treat the convergence, not the calendar, and not the color.

References
  1. Lemiengre MB, van Driel ML, Merenstein D, et al. Antibiotics for Acute Rhinosinusitis in Adults. Cochrane Database Syst Rev. 2018;9:CD006089.
  2. Rosenfeld RM. Acute Sinusitis in Adults. N Engl J Med. 2016;375(10):962–970.
  3. Meeker D, Linder JA, Fox CR, et al. Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial. JAMA. 2016;315(6):562–570.
  4. Spurling GK, Dooley L, Clark J, Askew DA. Immediate Versus Delayed Versus No Antibiotics for Respiratory Infections. Cochrane Database Syst Rev. 2023;10:CD004417.
  5. Payne SC, McKenna M, Buckley J, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngol Head Neck Surg. 2025;173(Suppl 1):S1–S56.
  6. Harris AM, Hicks LA, Qaseem A. Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the ACP and the CDC. Ann Intern Med. 2016;164(6):425–434.

For informational and educational purposes only. Clinical judgment applies in all patient encounters. Hard contraindications and medication interactions are clinical decisions to be made by the treating clinician.